Market News
2 min read | Updated on April 16, 2025, 07:37 IST
SUMMARY
PB Fintech share price: "We are pleased to inform that RBI has granted an in-principle authorisation to PB Pay to operate as an online payment aggregator under the Payment and Settlement Systems Act, 2007," PB Fintech said in a late-evening regulatory filing.
Stock list
PB Fintech reported a 92% jump in its consolidated profit after tax (PAT) to ₹71.54 crore in the third quarter of the fiscal year 2024-25 (Q3 FY25). | Image: Shutterstock
Last year, the company had announced setting up a wholly owned subsidiary – PB Pay Private Limited (PB Pay) – to apply to the Reserve Bank of India (RBI) for obtaining a Certificate of Registration (CoR) as an NBFC Payment Aggregator (NBFC-PA).
"In this regard, we are pleased to inform that RBI has granted an in-principle authorisation to PB Pay to operate as an online payment aggregator under the Payment and Settlement Systems Act, 2007," PB Fintech said in a late-evening regulatory filing.
The in-principle authorisation is, however, subject to adherence to the guidelines on Regulation of Payment Aggregators and Payment Gateways dated March 17, 2020, it added.
The paid-up share capital of the proposed company will be ₹27 crore.
The said investment is, however, subject to the shareholder's approval through postal ballot and will be made along with other external investors in PB Healthcare Services Private Ltd, it said.
It further said that the capital infusion would be done to meet its general operating expenses and enhance brand awareness, office presence and strategic initiatives.
PB Healthcare Services Private Ltd. was incorporated in January 2025 to carry on the business of healthcare and allied services in India.
PB Fintech reported a 92% jump in its consolidated profit after tax (PAT) to ₹71.54 crore in the third quarter of the fiscal year 2024-25 (Q3 FY25) from ₹37.23 crore logged in the year-ago quarter, buoyed by healthy insurance premium collection.
The company clocked an EBITDA profit of ₹28 crore during the quarter under review against an EBITDA loss of ₹25 crore in Q3 FY24.
About The Author
Next Story